Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer After Upfront FOLFIRINOX Versus FOLFIRINOX Only

202122 citationsJournal Articlegreen Open Access

Authors

L. Brada · University Medical Center Utrecht

Lois A. Daamen · University Medical Center Utrecht

L. Magermans · St. Antonius Ziekenhuis

Marieke S. Walma · University Medical Center Utrecht

Diba Latifi · Erasmus MC

Ronald M. van Dam · Maastricht University

Ignace H. J. T. de Hingh

Abstract

Resection of LAPC after FOLFIRINOX was associated with increased OS and 3-year survival, as compared to propensity-score matched patients treated with FOLFIRINOX-only.

Topics & Keywords

Pancreatic and Hepatic Oncology Research Cancer Genomics and Diagnostics Renal cell carcinoma treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Surgery

Volume 274, Issue 5, pp. 729-735

DOI: 10.1097/sla.0000000000005120

Field-Weighted Citation Impact: 1.70